GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Earnings per Share (Diluted)

DaVita (DaVita) Earnings per Share (Diluted)

: $7.40 (TTM As of Dec. 2023)
View and export this data going back to 1995. Start your Free Trial

DaVita's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $1.62. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.40.

DaVita's EPS (Basic) for the three months ended in Dec. 2023 was $1.67. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.61.

DaVita's EPS without NRI for the three months ended in Dec. 2023 was $1.87. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $7.82.

During the past 12 months, DaVita's average EPS without NRIGrowth Rate was 48.30% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 6.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.10% per year.

During the past 13 years, DaVita's highest 3-Year average EPS without NRI Growth Rate was 117.40% per year. The lowest was -22.80% per year. And the median was 11.65% per year.


DaVita Earnings per Share (Diluted) Historical Data

The historical data trend for DaVita's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.27 6.31 8.90 5.85 7.42

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 1.25 1.91 2.62 1.62

Competitive Comparison

For the Medical Care Facilities subindustry, DaVita's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita PE Ratio Distribution

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's PE Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's PE Ratio falls into.



DaVita Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

DaVita's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(691.535-0)/93.182
=7.42

DaVita's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(150.665-0)/92.777
=1.62

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


DaVita  (NYSE:DVA) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


DaVita Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of DaVita's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (DaVita) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
Christopher Michael Berry officer: Chief Accounting Officer C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale director
Javier Rodriguez officer: Chief Executive Officer, DKC 601 HAWAII ST., EL SEGUNDO CA 90245
Barbara J Desoer director CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra director 1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
Pamela M Arway director 601 HAWAII ST., EL SEGUNDO CA 90245
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601

DaVita (DaVita) Headlines

From GuruFocus

Q2 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

DaVita Inc 2021 Capital Markets Day Transcript

By GuruFocus Research 01-22-2024

Q3 2019 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024